转甲状腺素蛋白心脏淀粉样变磁共振影像学进展  

Magnetic Resonance Imaging of Transthyretin Cardiac Amyloidosis

作　　者：熊群 董剑廷[1] 杨昂[2] XIONG Qun;DONG Jianting;YANG Ang(Clinical Cardiology Unit,Zhongshan Affiliated Hospital of Sun Yat-sen University,Zhongshan 528400,Guangdong,China;Department of Magnetic Resonance Imaging,Zhongshan Affiliated Hospital of Sun Yat-sen University,Zhongshan 528400,Guangdong,China)

机构地区：[1]中山大学附属中山医院心脏中心,广东中山528400 [2]中山大学附属中山医院核磁共振室,广东中山528400

出　　处：《心血管病学进展》2022年第4期305-308,330,共5页Advances in Cardiovascular Diseases

摘　　要：转甲状腺素蛋白心脏淀粉样变既往诊断率低、病死率高,但随着无创影像学诊断模式的不断发展,该疾病的早期检出率不断升高。心脏磁共振成像具有全面、多参数的成像序列,可早期识别淀粉样变心肌功能及结构的异常,具有早期诊断、评估预后的能力。现对转甲状腺素蛋白心脏淀粉样变的磁共振影像学研究进展进行综述。The diagnosis rate of transthyretin cardiac amyloidosis,which was underestimated in the past with high mortality,has been climbing up in recent years with the development of non-invasive imaging diagnosis strategy.Cardiac magnetic resonance imaging has been proven reliable in early identifying abnormalities of amyloidosis myocardial function and structure for its comprehensive and multi-parameter imaging sequences,which has been applied in clinical practice for early diagnosis and prognosis assessment.Therefore,this review aims to summarize the progress of magnetic resonance imaging of transthyretin amyloid heart disease to date.

关 键 词：心脏淀粉样变 磁共振成像 转甲状腺素蛋白 

分 类 号：R44[医药卫生—诊断学]